Is DOTS-plus a feasible and cost-effective strategy?
- PMID: 16968122
- PMCID: PMC1564173
- DOI: 10.1371/journal.pmed.0030350
Is DOTS-plus a feasible and cost-effective strategy?
Abstract
Paul Garner and colleagues discuss the implications of the pilot study by Katherine Floyd and colleagues of the DOTS-Plus project for tuberculosis control in the Philippines.
Conflict of interest statement
Comment on
-
Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines.PLoS Med. 2006 Sep;3(9):e352. doi: 10.1371/journal.pmed.0030352. PLoS Med. 2006. PMID: 16968123 Free PMC article.
References
-
- Dye C, Floyd K. Chapter 16: Tuberculosis. Disease control priorities in developing countries. 2nd edition. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al., editors. New York: The World Bank and Oxford University Press; 2006. pp. 289–309. Available: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=dcp2.chapter.1737. Accessed 27 July 2006. - PubMed
-
- Tupasi TE, Gupta R, Quelapio MID, Quelapio RB, Mira NR, et al. Feasibility and cost-effectiveness of treating patients with multidrug-resistant tuberculosis using the DOTS-Plus strategy: A cohort study in the Philippines. PLoS Med. 2006;3:e352. DOI: 10.1371/journal.pmed.0030352. - DOI - PMC - PubMed
-
- The Stop TB Partnership. Geneva: World Health Organization; 2006. The global plan to stop TB 2006–2015. Available: http://www.stoptb.org/globalplan/assets/documents/GlobalPlanFinal.pdf. Accessed 27 July 2006.
-
- Travis P, Bennett S, Haines A, Pang T, Bhutta Z, et al. Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet. 2004;364:900–906. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources